Palo Alto, CA, United States of America

Timothy A Blauwkamp

This inventor holds 13 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Nucleic Acid Technologies. Top assignees: Karius, Inc., Oxford Finance LLC. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy A Blauwkamp. Retrieved from https://idiyas.com/inventor/timothy-a-blauwkamp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 51(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2018 - 2023)
  • Redwood City, CA (US) (2023)

Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Infectious Disease Detection
Nucleic Acid Enrichment
Sample Preparation
Synthetic Spike-Ins
Contaminant Differentiation
Library Methods
Compositions
Prediction Methods
Population Enrichment
Nucleic Acid Technologies
Sample Series
Direct-to-Library
13 patents (USPTO):Explore Patents

Title: The Innovations of Timothy A. Blauwkamp

Introduction

Timothy A. Blauwkamp is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid research. With a total of 13 patents to his name, Blauwkamp's work has had a substantial impact on the detection and diagnosis of diseases.

Latest Patents

Among his latest patents are innovative methods and systems that enhance the efficiency of nucleic acid enrichment. One notable patent is focused on direct-to-library methods, systems, and compositions. This patent outlines techniques that streamline the process of preparing nucleic acid libraries for analysis. Another significant patent involves compositions and methods for enriching populations of nucleic acids. This disclosure provides valuable methods and compositions that are particularly useful for detecting, predicting, diagnosing, or monitoring diseases caused by foreign microbes or pathogens.

Career Highlights

Timothy A. Blauwkamp is currently associated with Karius, Inc., a company that specializes in advanced diagnostic solutions. His work at Karius has allowed him to further develop his innovative ideas and contribute to the advancement of medical diagnostics. His expertise in nucleic acid research has positioned him as a key figure in the biotechnology sector.

Collaborations

Throughout his career, Blauwkamp has collaborated with notable professionals in the field, including Igor D. Vilfan and Rene Sit. These collaborations have fostered a dynamic exchange of ideas and have contributed to the success of his projects.

Conclusion

Timothy A. Blauwkamp's contributions to biotechnology through his patents and work at Karius, Inc. highlight his role as an influential inventor. His innovative approaches to nucleic acid research continue to pave the way for advancements in medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…